This interactive course is made up of 11 modules illustrating the key pharmaceutical supply chain stakeholders and their functions as products move from the manufacturer to the customer.
(Webinar Held: May 4, 2021) HDA hosts a virtual discussion with four leaders driving diversity, equity and inclusion (DE&I) efforts within the healthcare supply chain.
(Webinar Held: January 27, 2021) Join HDA and The Hill for a virtual conversation between policymakers, leaders in the pharmaceutical and distribution industries and public health experts on how vaccines...
The 91st Edition HDA Factbook (2020–2021) provides comprehensive distribution performance metrics that highlight growth and trends in the pharmaceutical industry.
NON - MEMBER PRICE: $0.00 | MEMBER PRICE: $0.00
Product returns are inevitable. Annually, more than 120 million product units — exceeding $13 billion in value — move through the reverse distribution process.
PRICE : $0.00 - $0.00
This whitepaper provides an analysis of the current market for biosimilars in the U.S. through interviews conducted with senior executives from specialty pharmaceutical manufacturing and distribution companies.
Through interviews, survey work and secondary data, this publication provides an understanding of the role distributors play to ensure the efficient and effective distribution of specialty medications.
The information conveyed about new products has critical downstream implications that can affect the appropriate receiving, handling and storage at the distributor’s facility and farther along the healthcare...
This report summarizes the results of the pilot study conducted by HDA, working with Ernst & Young LLP (EY) and HDA’s Traceability Pilots Work Group.
Developed by HDMA’s eCommerce Task Force, these electronic data interchange sets provide guidance to trading partners on business practices related to merchandise returns and debit or memos that can be...
PRICE : $0.00 - $495.00
Developed by HDMA’s eCommerce Task Force, the 810 Invoice Guidelines for EDI support the order-to-cash cycle.
Developed by HDA’s eCommerce Task Force, this electronic data interchange (EDI) set is intended for use in the healthcare manufacturer bid award/change notice process.
Developed by HDA’s eCommerce Task Force, this electronic data interchange (EDI) set is intended for use within the chargeback process (i.e., reconciliation).
Developed by HDMA’s eCommerce Task Force, these three electronic data interchange (EDI) sets are used to administer contract and chargeback transactions.